Crossref
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Clinical Investigation · 2011
DOI: 10.4155/cli.10.28 ↗At a glance
Journal article in Clinical Investigation, 2011. Written by Javier Rueda and 2 co-authors. 68 references.
Abstract (original language)
Abstract non disponibile.
Cite
APA
Rueda, J., González-Gay, M. A., & Blanco, R. (2011). Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program. Clinical Investigation. https://doi.org/10.4155/cli.10.28
Vancouver
Rueda J, González-Gay MA, Blanco R. Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program. Clinical Investigation. 2011. doi:10.4155/cli.10.28
BibTeX
@article{Rueda2011,
author = {Rueda, Javier and González-Gay, Miguel A and Blanco, Ricardo},
title = {Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program},
journal = {Clinical Investigation},
year = {2011},
doi = {10.4155/cli.10.28}
}
EUVIMED